Incentive Design Using Stock Acquisition Rights Subject to Performance and Share Price Conditions
First written in FY2016-Q2. 15 of 26 entries say "Advanced", first in FY2017-Q2. Latest entry: 2026-08-17.
The whole theme swung hardest in 2020: 2 of 10 companies on the "Worse" side.
3 other companies' latest entry also says "Achieved".
- 2026-08-17AchievedShare Issuance and Disposal
「Regarding the issuance of new shares as a restricted stock incentive for the employee stock ownership association, which was resolved at the Board of Directors meeting held on 17 April 2026, the company announces that the payment procedures were completed today, as follows.」
Payment procedures for the restricted stock incentive for the employee stock ownership association disclosed on 17 April 2026 were completed. Following partial forfeiture due to the finalization of the eligible employees, the number of shares issued changed from 132,122 shares to 103,988 shares, and the total issue amount changed from ¥136,217,782 to ¥107,211,628. - FY2026-H1AdvancedAnnual report
「13 February 2026 (Note) 1 3,299 11,415,608 2 897 2 2,194／13 May 2026 (Note) 3 33,127 11,477,135 17 922 17 2,219」
As restricted stock compensation, the Company issued 3,299 shares to 8 subsidiary directors in February 2026 and 33,127 shares to 7 Company directors and 8 subsidiary directors in May of the same year. - FY2025RaisedAnnual report
「If the proposal concerning the revision of compensation for the allocation of restricted stock to directors, excluding directors who are Audit and Supervisory Committee members and non-executive directors, which is an agenda item for resolution at the 62nd Annual General Meeting of Shareholders scheduled for 27 March 2026, is approved, the total amount of monetary compensation claims to be paid to the Company's directors, excluding directors who are Audit and Supervisory Committee members and non-executive directors, as compensation related to restricted stock will be revised to no more than ¥35 million per year.」
A proposal to raise the annual cap on restricted stock compensation from ¥20 million to ¥35 million has been submitted to the Annual General Meeting of Shareholders scheduled for 27 March 2026. - FY2025-H1AdvancedAnnual report
「14 February 2025 3,904 11,393,015 1 885 1 2,182／14 May 2025 19,294 11,412,309 9 895 9 2,192」
As restricted stock compensation, the Company issued 3,904 shares to 4 subsidiary directors on 14 February 2025 and 19,294 shares to 7 Company directors on 14 May 2025. - FY2024-H1AdvancedAnnual report
「The increase resulted from the issuance of new shares as restricted stock compensation.」
On 13 May 2024, the Company issued 19,507 new shares related to restricted stock compensation to 5 Company directors as the allottees. The issue price was ¥834 and the amount included in capital was ¥417 per share. - FY2024-Q1AdvancedAnnual report
「15 February 2024 (Note) 1 2,892 11,369,604 1 875 1 2,172」
As restricted stock compensation, the Company issued 2,892 new shares on 15 February 2024 to 2 directors of a subsidiary as the allottees. - FY2023AdvancedAnnual report
「Holders of the stock acquisition rights may exercise these stock acquisition rights thereafter only if (i) the total consolidated ordinary income for any consecutive 2 fiscal years from the fiscal year ending December 2024 exceeds ¥3,000 million and (ii), by the date on which 1 year has elapsed from 1 April of the year following the fiscal year in which (i) was achieved, the Company's market capitalization has exceeded ¥30,000 million at least once.」
In addition to the existing stock compensation-type stock options, the Company issued stock acquisition rights for directors in November 2023, setting exercise conditions combining consolidated ordinary income of more than ¥3,000 million with a market capitalization of more than ¥30 billion. It also issued stock acquisition rights for 562 employees and officers of subsidiaries subject to consolidated ordinary income exceeding ¥2,500 million. - FY2023-Q2AdvancedAnnual report
「The increase resulted from the issuance of new shares as restricted stock compensation.」
On 15 May 2023, the Company issued 13,226 new shares as restricted stock compensation to 4 directors as the allottees, and additionally issued 11,600 shares through the exercise of stock acquisition rights during the second quarter accounting period. - FY2022-Q3Continued exercise of stock acquisition rightsAnnual report
「The increase resulted from the exercise of share acquisition rights.」
From July to September 2022, the exercise of stock acquisition rights increased the total number of shares issued by 200. - FY2022-Q1AdvancedAnnual report
「Pursuant to a resolution of the Board of Directors meeting held on 15 April 2022, the Company issued new shares on 13 May 2022 as restricted stock compensation for its directors, excluding directors who are Audit and Supervisory Committee members and non-executive directors. As a result, the number of shares issued increased by 10,043.」
Based on its policy of changing from the existing stock compensation-type stock option plan to restricted stock compensation, the Company issued 10,043 new shares. - FY2021ReframedAnnual report
「Based on a resolution at the 58th Annual General Meeting of Shareholders held on 29 March 2022, the Company introduced a restricted stock compensation plan. In connection with this, it abolished the existing stock compensation-type stock option plan and will make no new allocations of stock acquisition rights, other than those already granted.」
The Company disclosed its policy of changing from the existing stock compensation-type stock option plan to restricted stock compensation. During the fiscal year, it also granted Seventh Series Stock Acquisition Rights and received exercises of existing stock acquisition rights. - FY2021-Q2AdvancedAnnual report
「4 Company directors (excluding directors who are Audit and Supervisory Committee members and non-executive directors)」
For the Seventh Series Stock Compensation-Type Stock Acquisition Rights resolved on 30 March 2021, the Company issued 69 rights covering 6,900 shares to 4 directors. During the cumulative second quarter period, it also issued 97,000 shares through the exercise of stock acquisition rights, increasing capital and the capital surplus by ¥26,811 thousand each. - FY2020-Q3Adjustment of exercise price due to stock splitAnnual report
「In connection with this stock split, the exercise price per share of the stock acquisition rights issued by the Company will be adjusted as follows from Friday, 1 January 2021.」
The Company disclosed that, in connection with the 1-for-2 stock split scheduled to take effect on 1 January 2021, the exercise price of the First Series Stock Acquisition Rights would be adjusted from ¥1,098 to ¥549. - FY2019AdvancedAnnual report
「(Sixth Series Stock Compensation-Type Stock Acquisition Rights) Resolution date: 27 March 2020; category and number of grantees: 4 Company directors (excluding outside directors and part-time directors)」
The Company resolved to issue Sixth Series Stock Compensation-Type Stock Acquisition Rights to 4 directors. The issue comprised 180 stock acquisition rights covering 18,000 shares, with an exercise period from 21 April 2020 to 20 April 2050. - FY2019-Q1Exercise of Stock Acquisition RightsAnnual report
「28 March 2019 8,300 4,851,055 4,418 792,324 4,418 867,343」
On 28 March 2019, stock acquisition rights were exercised, increasing the total number of shares issued by 8,300 and increasing capital and the capital surplus by ¥4,418 thousand each. - FY2018AdvancedAnnual report
「(Fifth Series Stock Compensation-Type Stock Acquisition Rights) Resolution date: 27 March 2019; category and number of grantees: 4 Company directors (excluding outside directors and part-time directors)」
The Company resolved on 27 March 2019 to issue Fifth Series Stock Compensation-Type Stock Acquisition Rights to 4 directors. The issue comprised 116 stock acquisition rights covering 11,600 shares, with an exercise period from 16 April 2019 to 15 April 2049. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows: Fourth Series Stock Compensation-Type Stock Acquisition Rights (resolved at the Board of Directors meeting on 27 March 2018).」
The Company issued Fourth Series Stock Compensation-Type Stock Acquisition Rights resolved on 27 March 2018. The issue comprised 112 stock acquisition rights covering 11,200 shares, with an exercise period from 17 April 2018 to 16 April 2048. - FY2017AdvancedAnnual report
「(Fourth Series Stock Compensation-Type Stock Acquisition Rights) Resolution date: 27 March 2018; category and number of grantees: 5 Company directors (excluding outside directors)」
The Company resolved on 27 March 2018 to issue Fourth Series Stock Compensation-Type Stock Acquisition Rights to 5 directors. - FY2017-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows: Third Series Stock Compensation-Type Stock Acquisition Rights (resolved at the Board of Directors meeting on 28 March 2017).」
The Company newly issued Third Series Stock Compensation-Type Stock Acquisition Rights. The exercise period is from 18 April 2017 to 17 April 2047, and the rights may be exercised only upon loss of director status. - FY2016RestatedAnnual report
「・At least ¥1.1 billion: 100% exercisable・At least ¥900 million: 50% exercisable」
The Company continues to disclose the incentive plan for stock acquisition rights combining ordinary income for the fiscal year ending December 2020 with share price conditions applicable from 1 April 2021 to 30 June 2023. - FY2016-Q2First statedAnnual report
「If ordinary income in the consolidated income statement stated in the Company's annual securities report for the fiscal year ending December 2020 (or in the income statement if consolidated financial statements are not prepared) reaches at least the following amount, the exercisable percentage will be determined according to the applicable category.・At least ¥1.1 billion: 100% exercisable・At least ¥900 million: 50% exercisable」
The Company issued stock acquisition rights subject to a condition of ordinary income for the fiscal year ending December 2020 and a share price of at least ¥1,500 during the period from 1 April 2021 to 30 June 2023.